129 related articles for article (PubMed ID: 12480736)
41. Cerebral blood flow and cerebrovascular reactivity are preserved in a mouse model of cerebral microvascular amyloidosis.
Munting LP; Derieppe M; Suidgeest E; Hirschler L; van Osch MJ; Denis de Senneville B; van der Weerd L
Elife; 2021 Feb; 10():. PubMed ID: 33577447
[TBL] [Abstract][Full Text] [Related]
42. Selective benefits of simvastatin in bitransgenic APPSwe,Ind/TGF-β1 mice.
Papadopoulos P; Tong XK; Hamel E
Neurobiol Aging; 2014 Jan; 35(1):203-12. PubMed ID: 23954171
[TBL] [Abstract][Full Text] [Related]
43. Nilvadipine antagonizes both Abeta vasoactivity in isolated arteries, and the reduced cerebral blood flow in APPsw transgenic mice.
Paris D; Quadros A; Humphrey J; Patel N; Crescentini R; Crawford F; Mullan M
Brain Res; 2004 Feb; 999(1):53-61. PubMed ID: 14746921
[TBL] [Abstract][Full Text] [Related]
44. Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology.
Town T; Laouar Y; Pittenger C; Mori T; Szekely CA; Tan J; Duman RS; Flavell RA
Nat Med; 2008 Jun; 14(6):681-7. PubMed ID: 18516051
[TBL] [Abstract][Full Text] [Related]
45. Passive immunotherapy targeting amyloid-β reduces cerebral amyloid angiopathy and improves vascular reactivity.
Bales KR; O'Neill SM; Pozdnyakov N; Pan F; Caouette D; Pi Y; Wood KM; Volfson D; Cirrito JR; Han BH; Johnson AW; Zipfel GJ; Samad TA
Brain; 2016 Feb; 139(Pt 2):563-77. PubMed ID: 26493635
[TBL] [Abstract][Full Text] [Related]
46. Differentially expressed cortical genes contribute to perivascular deposition in transgenic mice with inducible neuron-specific expression of TGF-beta1.
Ueberham U; Zobiak B; Ueberham E; Brückner MK; Boriss H; Arendt T
Int J Dev Neurosci; 2006; 24(2-3):177-86. PubMed ID: 16386398
[TBL] [Abstract][Full Text] [Related]
47. Intact memory in TGF-β1 transgenic mice featuring chronic cerebrovascular deficit: recovery with pioglitazone.
Nicolakakis N; Aboulkassim T; Aliaga A; Tong XK; Rosa-Neto P; Hamel E
J Cereb Blood Flow Metab; 2011 Jan; 31(1):200-11. PubMed ID: 20571524
[TBL] [Abstract][Full Text] [Related]
48. Neurovascular uncoupling in the triple transgenic model of Alzheimer's disease: Impaired cerebral blood flow response to neuronal-derived nitric oxide signaling.
Lourenço CF; Ledo A; Barbosa RM; Laranjinha J
Exp Neurol; 2017 May; 291():36-43. PubMed ID: 28161255
[TBL] [Abstract][Full Text] [Related]
49. Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons.
Van Dorpe J; Smeijers L; Dewachter I; Nuyens D; Spittaels K; Van Den Haute C; Mercken M; Moechars D; Laenen I; Kuiperi C; Bruynseels K; Tesseur I; Loos R; Vanderstichele H; Checler F; Sciot R; Van Leuven F
Am J Pathol; 2000 Oct; 157(4):1283-98. PubMed ID: 11021833
[TBL] [Abstract][Full Text] [Related]
50. Dysfunction of TGF-β1 signaling in Alzheimer's disease: perspectives for neuroprotection.
Caraci F; Spampinato S; Sortino MA; Bosco P; Battaglia G; Bruno V; Drago F; Nicoletti F; Copani A
Cell Tissue Res; 2012 Jan; 347(1):291-301. PubMed ID: 21879289
[TBL] [Abstract][Full Text] [Related]
51. Insulin-degrading enzyme deficiency accelerates cerebrovascular amyloidosis in an animal model.
Lifshitz V; Benromano T; Weiss R; Blanga-Kanfi S; Frenkel D
Brain Behav Immun; 2013 May; 30():143-9. PubMed ID: 23257117
[TBL] [Abstract][Full Text] [Related]
52. Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's disease.
Bourasset F; Ouellet M; Tremblay C; Julien C; Do TM; Oddo S; LaFerla F; Calon F
Neuropharmacology; 2009 Mar; 56(4):808-13. PubMed ID: 19705573
[TBL] [Abstract][Full Text] [Related]
53. High-Fat-Diet Intake Enhances Cerebral Amyloid Angiopathy and Cognitive Impairment in a Mouse Model of Alzheimer's Disease, Independently of Metabolic Disorders.
Lin B; Hasegawa Y; Takane K; Koibuchi N; Cao C; Kim-Mitsuyama S
J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27412896
[TBL] [Abstract][Full Text] [Related]
54. GDF11 Rejuvenates Cerebrovascular Structure and Function in an Animal Model of Alzheimer's Disease.
Zhang W; Guo Y; Li B; Zhang Q; Liu JH; Gu GJ; Wang JH; Bao RK; Chen YJ; Xu JR
J Alzheimers Dis; 2018; 62(2):807-819. PubMed ID: 29480172
[TBL] [Abstract][Full Text] [Related]
55. Effect of anti-inflammatory agents on transforming growth factor beta over-expressing mouse brains: a model revised.
Lacombe P; Mathews PM; Schmidt SD; Breidert T; Heneka MT; Landreth GE; Feinstein DL; Galea E
J Neuroinflammation; 2004 Jul; 1(1):11. PubMed ID: 15285804
[TBL] [Abstract][Full Text] [Related]
56. Protection of TGF-β1 against neuroinflammation and neurodegeneration in Aβ1-42-induced Alzheimer's disease model rats.
Chen JH; Ke KF; Lu JH; Qiu YH; Peng YP
PLoS One; 2015; 10(2):e0116549. PubMed ID: 25658940
[TBL] [Abstract][Full Text] [Related]
57. Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways.
Wojtas AM; Kang SS; Olley BM; Gatherer M; Shinohara M; Lozano PA; Liu CC; Kurti A; Baker KE; Dickson DW; Yue M; Petrucelli L; Bu G; Carare RO; Fryer JD
Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6962-E6971. PubMed ID: 28701379
[TBL] [Abstract][Full Text] [Related]
58. Vasoactive effects of A beta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer's disease: role of inflammation.
Paris D; Humphrey J; Quadros A; Patel N; Crescentini R; Crawford F; Mullan M
Neurol Res; 2003 Sep; 25(6):642-51. PubMed ID: 14503019
[TBL] [Abstract][Full Text] [Related]
59. Prenatal high-fat diet alters the cerebrovasculature and clearance of β-amyloid in adult offspring.
Hawkes CA; Gentleman SM; Nicoll JA; Carare RO
J Pathol; 2015 Mar; 235(4):619-31. PubMed ID: 25345857
[TBL] [Abstract][Full Text] [Related]
60. Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy.
Hawkes CA; Härtig W; Kacza J; Schliebs R; Weller RO; Nicoll JA; Carare RO
Acta Neuropathol; 2011 Apr; 121(4):431-43. PubMed ID: 21259015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
